We have located links that may give you full text access.
A discrete-choice experiment to assess treatment modality preferences of patients with depression.
Journal of Medical Economics 2018 December 2
AIMS: There is an increasing interest in understanding patients' preferences in the area of healthcare decision making to better match treatment with patients' preferences and improve treatment uptake and adherence. The aim of this study was to elicit the preferences of patients with a depressive disorder regarding treatment modalities.
MATERIALS AND METHODS: In a discrete-choice experiment, patients chose repetitively between two hypothetical depression treatments that varied in four treatment attributes: waiting time until the start of treatment, treatment intensity, level of digitalisation, and group size. A Bayesian-efficient design was used to develop twelve choice sets and patients' preferences and preference variation was estimated using a random parameters logit model.
RESULTS: A total of 165 patients with depression completed the survey. Patients preferred short (over long) waiting times, face-to-face (over digital) treatment, individual (over group) treatment, and one session per week over two sessions per week or one session per two weeks. Patients disfavoured digital treatment and treatment in a large group. Waiting time and treatment intensity were substantially less important attributes to patients than face-to-face (versus digital) and group size. Significant variation in preferences was observed for each attribute and subgroup analyses revealed that these differences were in part related to age and education.
LIMITATIONS: The convenience sample overrepresented the female and younger population, limiting generalizability. Limited information on background characteristics limited the possibilities to explore preference heterogeneity.
CONCLUSION: This study demonstrated how different treatment components for depression affect patients' preferences for those treatments. There is significant variation in treatment preferences, even after accounting for age and education. Incorporating individual patients' preferences into treatment decisions could potentially lead to improved adherence of treatments for depressive disorders.
MATERIALS AND METHODS: In a discrete-choice experiment, patients chose repetitively between two hypothetical depression treatments that varied in four treatment attributes: waiting time until the start of treatment, treatment intensity, level of digitalisation, and group size. A Bayesian-efficient design was used to develop twelve choice sets and patients' preferences and preference variation was estimated using a random parameters logit model.
RESULTS: A total of 165 patients with depression completed the survey. Patients preferred short (over long) waiting times, face-to-face (over digital) treatment, individual (over group) treatment, and one session per week over two sessions per week or one session per two weeks. Patients disfavoured digital treatment and treatment in a large group. Waiting time and treatment intensity were substantially less important attributes to patients than face-to-face (versus digital) and group size. Significant variation in preferences was observed for each attribute and subgroup analyses revealed that these differences were in part related to age and education.
LIMITATIONS: The convenience sample overrepresented the female and younger population, limiting generalizability. Limited information on background characteristics limited the possibilities to explore preference heterogeneity.
CONCLUSION: This study demonstrated how different treatment components for depression affect patients' preferences for those treatments. There is significant variation in treatment preferences, even after accounting for age and education. Incorporating individual patients' preferences into treatment decisions could potentially lead to improved adherence of treatments for depressive disorders.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app